agilon health, inc. (NYSE:AGL) Receives Average Recommendation of "Hold" from Analysts

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been assigned an average rating of "Hold" from the eighteen research firms that are currently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $4.03.

Several research analysts recently issued reports on the company. Stifel Nicolaus cut their price objective on agilon health from $7.00 to $2.00 and set a "hold" rating for the company in a research report on Tuesday, November 12th. William Blair cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th. TD Cowen lowered their target price on shares of agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a research note on Monday, November 11th. JMP Securities cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. Finally, Citigroup upgraded shares of agilon health from a "sell" rating to a "neutral" rating and boosted their price objective for the stock from $1.75 to $2.25 in a report on Friday, January 10th.

Insider Activity at agilon health

In other agilon health news, Director Diana Mckenzie acquired 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was acquired at an average price of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John William Wulf acquired 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 90,000 shares of company stock valued at $198,100 in the last quarter. Insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in agilon health by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after purchasing an additional 272,787 shares during the last quarter. Capital International Investors grew its position in agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the last quarter. State Street Corp grew its position in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock worth $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Geode Capital Management LLC grew its position in agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock worth $13,168,000 after purchasing an additional 35,207 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock worth $8,629,000 after purchasing an additional 1,498,524 shares during the last quarter.

agilon health Price Performance

Shares of agilon health stock traded down $0.06 during trading on Thursday, hitting $3.43. 4,629,136 shares of the company were exchanged, compared to its average volume of 5,376,274. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The stock has a market capitalization of $1.41 billion, a price-to-earnings ratio of -3.64 and a beta of 0.67. The firm has a 50 day moving average price of $2.69 and a 200 day moving average price of $3.16.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.